Works matching AU Tomita, Aiko

Results: 4
    1

    Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY.

    Published in:
    Clinical & Experimental Nephrology, 2024, v. 28, n. 6, p. 588, doi. 10.1007/s10157-024-02489-4
    By:
    • Nangaku, Masaomi;
    • Herrington, William G.;
    • Goto, Shinya;
    • Maruyama, Shoichi;
    • Kashihara, Naoki;
    • Ueki, Kohjiro;
    • Wada, Jun;
    • Watada, Hirotaka;
    • Nakashima, Eitaro;
    • Lee, Ryonfa;
    • Massey, Dan;
    • Mayne, Kaitlin J.;
    • Tomita, Aiko;
    • Haynes, Richard;
    • Hauske, Sibylle J.;
    • Kadowaki, Takashi
    Publication type:
    Article
    2
    3
    4

    A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

    Published in:
    Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 5, p. 435, doi. 10.1016/S0009-9236(03)00014-6
    By:
    • Watanabe, Ichiro;
    • Tomita, Aiko;
    • Shimizu, Miho;
    • Sugawara, Mie;
    • Yasumo, Hiroaki;
    • Koishi, Ryuta;
    • Takahashi, Tohru;
    • Miyoshi, Kaoru;
    • Nakamura, Kouichi;
    • Izumi, Takashi;
    • Matsushita, Yasuyuki;
    • Furukawa, Hidehiko;
    • Haruyama, Hideyuki;
    • Koga, Teiichiro
    Publication type:
    Article